‘King Kong’ of weight loss drugs, will soon be available in the US market

Washington. Very soon King Kong of weight loss medicines will be in the market (US Market) and will leave behind all the medicines till now. This claim has been made by the American company Eli Lilly. He says that all those medicines which are currently occupying the market will be left behind, because all these medicines have side effects and such medicines only give side effects in the long run. It has been said about the new medicine that it is completely different from the old and unsuccessful methods and its results will be available at the fastest speed.

The results of the tests that have been done regarding the drug are encouraging and it is expected that the American drug controllers will allow this new drug to be launched soon. With the new drug, weight loss, obesity and other related diseases can be treated. Currently in the US this segment with a market value of more than $300 billion has been waiting for this drug for decades.

After long research, effective medicine has been developed on obesity
Daniel Skowronsky, chief scientific and medical officer of the drug company Eli Lilly, said that in every mission we undertake, we first look at what our competitors have done. Most importantly, who has done this work the fastest? And then we set a goal to move even faster. Speed ​​becomes our No. 1 incentive, which is difficult because it’s a cultural change.’ Since it changed its approach, in phases over the past decade, Lilly’s overall R&D output has been among the industry’s most prodigious. The company has 19 new prescription drugs approved in the US or other countries since 2014 for conditions such as cancer, migraine and COVID-19. This has reduced their development timeline from 11 to an average of six years.

First read breaking news in Hindi News18 Hindi| Read today’s latest news, live news updates, most reliable Hindi news website News18 Hindi.

Tags: Drug, Obesity, Us market